(Q33339243)
Statements
1 reference
Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks (English)
1 reference
Minami H
1 reference
Fujii H
1 reference
Igarashi T
1 reference
Itoh K
1 reference
Tamanoi K
1 reference
Oguma T
1 reference
Sasaki Y
1 reference
1 October 2001
1 reference
1 reference
10
1 reference
3056-3064
1 reference
Identifiers
1 reference